title: Long-term remission in an aggressive Crooke cell adenoma of the pituitary, 18 months after discontinuation of treatment with temozolomide.
abstract: The clinical course of our patient, who sustained remission status for at least 18 months highlights the chance of long-term hormonal and tumor remission and demonstrates the efficacy and safety of discontinuation of temozolomide therapy. Prospective studies are required in order to define predictors of long-term remission of this promising therapeutic modality.
authors.affiliation: Department of Endocrinology, Evangelismos Hospital Athens, Greece.
authors.forename: Athina
authors.initials: A
authors.lastname: Asimakopoulou
authors.affiliation: Department of Endocrinology, Evangelismos Hospital Athens, Greece.
authors.forename: Marinela
authors.initials: M
authors.lastname: Tzanela
authors.affiliation: Department of Endocrinology, Evangelismos Hospital Athens, Greece.
authors.forename: Ageliki
authors.initials: A
authors.lastname: Koletti
authors.affiliation: Department of Pituitary Pathology, G. Genimatas Hospital Athens, Greece.
authors.forename: George
authors.initials: G
authors.lastname: Kontogeorgos
authors.affiliation: Department of Endocrinology, Evangelismos Hospital Athens, Greece.
authors.forename: Stylianos
authors.initials: S
authors.lastname: Tsagarakis
keywords: Crook's cell adenoma; Cushing's disease; temozolamide.